Glioma (grade 3)

  • Content
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Martin J van den Bent et al
Lancet. 2017 October 07; 390(10103): 1645–1653.

initial results from the catnon study, which resulted in addition of adjuvant TMZ to RT in non-codeleted grade 3 glioma

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
Martin J van den Bent et al
JCO VOLUME 24, NUMBER 18, JUNE 20 2006

seminal pair of papers that added PCV to the treatment of grade 3 glioma

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Gregory Cairncross, Meihua Wang, Edward Shaw, Robert Jenkins, David Brachman, Jan Buckner, Karen Fink, Luis Souhami, Normand Laperriere, Walter Curran, and Minesh Mehta
JCO 2012

the second seminal paper which added PCV to RT in grade 3 glioma